Concepedia

Author

Tímea Balatoni

National Institute of OncologyORCID

Also Known As

Balatoni, Tímea, Julie-Ann Francis, T. Balatoni, Timea Balatoni, Tímea Balatoni

36

Publications

349

Citations

11

H-Index

16

Concepts

All Affiliations

National Institute of OncologySemmelweis UniversityHarvard UniversityMassachusetts General HospitalUniversity of Szeged
TB

About

Tímea Balatoni is an author at National Institute of Oncology specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

83

2

Immunology

2

2

44

3

Pathology

2

2

38

4

Psychiatry

1

1

15

5

Cancer Therapeutics

1

1

24

Tímea Balatoni

×

9

Publications

258

Citations

9

H-Index

YearCitations

Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy

Tímea Balatoni, Anita Mohos, Eszter Papp,

Cancer Immunology Immunotherapy

2017

76

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vera Hirsh, Sandro Pignata, Melissa Bersanelli,

Journal of Translational Medicine

2017

43

Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Tímea Balatoni, Andrea Ladányi, Georgina Fröhlich,

Pathology & Oncology Research

2018

30

Melanoma and immunotherapy bridge 2015

Vashisht Gopal Yennu Nanda, Weiyi Peng, Patrick Hwu,

Journal of Translational Medicine

2016

24

Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data

Kata Czirbesz, Eszter Gorka, Tímea Balatoni,

Pathology & Oncology Research

2017

24

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma

Andrea Ladányi, Eszter Papp, Anita Mohos,

Journal for ImmunoTherapy of Cancer

2020

19

Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients

Péter Kovács, Gitta Pánczél, Tímea Balatoni,

Journal of Psychosomatic Research

2015

15

The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value

Beatrix Kotlán, Gabriella Liszkay, Miri Blank,

Immunologic Research

2014

14

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab

Andrea Ladányi, Barbara Hegyi, Tímea Balatoni,

Pathology & Oncology Research

2022

13

Page 1